Paracrine renal endothelin system in rats with liver cirrhosis

British Journal of Pharmacology

Volumn 118, Issue 2, 1996, Pages 220-227

  Hocher, Berthold ^a,c   Zart, Rüdiger ^c   Diekmann, Fritz ^a   Rohmeiss, Peter ^b   Distler, Armin ^a   Neumayer, Hans H ^a   Bauer, Christian ^c   Gross, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Bosentan; Endothelin; Endothelin receptor antagonist; Kidney dysfunction in liver cirrhosis; Liver cirrhosis; Paracrine renal endothelin system

Indexed keywords

BOSENTAN; CARBON TETRACHLORIDE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DIURESIS; GLOMERULUS FILTRATION RATE; KIDNEY CORTEX; LIVER CIRRHOSIS; MEAN ARTERIAL PRESSURE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SCATCHARD PLOT; SODIUM EXCRETION;

EID: 0029933174     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15390.x     Document Type: Article

References (51)

1. ARAI, H., HORI, S., ARAMORI, I., OHKUBO, H. & NAKANISHI, S. (1990). Cloning and expression of a cDNA encoding an endothelin receptor. Nature, 348, 730-732.
2. ARROYO, V., BERNARDI, M., EPSTEIN, M., HENRIKSEN, J.H. SCHRIER, R.W. & RODES J. (1988). Pathophysiology of ascites and functional renal failure in cirrhosis. J. Hepatol., 6, 239-257.
3. ASBERT, M., GINES, A., GINES, P., JIMENEZ, W., CLARIA, J., SALO, J., ARROYO, V., RIVERA, F. & RODES, J. (1993). Circulating levels of endothelin in cirrhosis. Gastroenterology, 104, 1485-91.
4. BOLGER, G.T., LIARD, F., JODOIN, A. & JARAMILLO, J. (1991). Vascular reactivity, tissue levels, and binding sites for endothelin: a comparison in the spontaneously hypertensive and Wistar-Kyoto rats. Can. J. Physiol. Pharmacol., 69, 406-413.
5. CLARIA, J., JIMENEZ, W., ARROYO, V., CASTRO, A., ASBERT, M., ROS, J., RIVERA, F. & RODES, J. (1991a). Doses of endothelin have natriuretic effects in conscious rats with cirrhosis and ascites. Kidney Int., 40, 182-7.
6. 1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites. Gastroenterology, 100, 494-501.
7. CLARIA, J., JIMENEZ, W., ROS, J., ASBERT, M., CASTRO, A., ARROYO, V., RIVERA, F. & RODES, J. (1992). Pathogenesis of arterial hypotension in cirrhotic rats with ascites; role of endogenous nitric oxide. Hepatology, 15, 343-349.
8. CLOZEL, M., BREU, V., GRAY, G.A., KALNA, B., LÖFFLER, B.M., BURRI, K., CASSAL, J.M., HIRTH, G., MÜLLER, M , NEIDHART, W. & RAMUZ, H. (1994). Pharmacological characterization of bosentan, a new potent orally active non-peptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther., 270, 228-235.
9. CLOZEL, M., LOFFLER, B.M., BREU, V., HILFIGER, L. & MAIRE, J.P. & BUTSCHA, B. (1993). Downregulation of endothelin receptors by autocrine production of endothelin-1. Am. J. Physiol., 265 (1 Pt 1), C188-92.
10. EDWARDS, R.M., STACK, E.J., PULLEN, M. & NAMBI, P. (1993). Endothelin inhibits vasopressin action in rat inner medullary collecting duct via the ETB receptor. J. Pharmacol. Exp. Ther., 267, 1028-1033.
11. EGUCHI, S., HIRATA, Y., IMAI, T. & MARUMO, F. (1994). C-type natriuretic peptide upregulates vascular endothelin type B receptors. Hypertension, 23, 936-940.
12. EPSTEIN, M. (1988). Hepatorenal syndrome. In The Kidney in Liver Disease. ed. Epstein, M. 3rd edn. pp. 3-30. Baltimore; Williams & Williams.
13. GANDHI, C.R., BEHAL, R., HARVEY, S., NOUCHI, T. & OLSON, M. (1992). Hepatic effects of endothelin. Biochem. J., 287, 897-904.
14. GANDHI, C.R., HARVEY, S.A. & OLSON, M. (1993). Hepatic effects of endothelin: metabolism of [125I]endothelin-1 by liver-derived cells. Arch. Biochem. Biophys.,305, 38-46.
15. +-ATPase activity in the rat proximal straight tubule. J. Am. Soc. Nephrol., 2, 976-982.
16. GELLAI, M., DEWOLF, R., PULLEN, M. & NAMBI, P. (1994). Distribution and functional role of renal ET receptor subtypes in normotensive and hypertensive rats. Kidney Int., 46, 1287-1294.
17. GINES, P., JIMENEZ, W., ARROYO, V., NAVASA, M., LOPEZ, C., TITO, L., SERRA, A., BOSCH, J., SANZ, G. & RIVERA, F. (1988). Atrial natriuretic factor in cirrhosis with ascites. Plasma levels, cardiac release and splanchnic extraction. Hepatology, 8, 636-642.
18. GRETZ, N., ECKER-TSCHIRNER, K.H., KÜHNLE, K.F., VON-DAHL, K., KIRSCHFINK, M., DRESCHER, P., LASSERRE, J.J. & STRAUCH, M. (1990). Practicability of the inulin plasma single-shot clearance. Contrb. Nephrol., 81, 220-228.
19. GROSS, P., RENN, C., WALDHERR, R., SEIFERT, M., BAEHR, R. & HOCHER, B. (1993). Potential role of endothelin in the physiological and pathological regulation of kidney function. Endothelium, 1, 71-83.
20. HAENDLER, B., HECHLER, U. & SCHLEUNING, W.D. (1992). Molecular cloning of human endothelin (ET) receptors ETA and ETB. J. Cardiovasc. Pharmacol., 20 Suppl 12:51-4.
21. 1-cells; Evidence for receptor-mediated endocytosis. Biochem. Biophys. Res. Commun., 186, 1376-1383.
22. HOCHER, B., ROHMEISS, P., ZART, R., DIEKMANN, F., BRAUN, C., KOPPENHAGEN, K., BAUER, C., DISTLER, A. & GRETZ, N. (1995). Distribution of endothelin receptor subtypes in the rat kidney. Renal and haemodynamic effects of the mixed (A/B) endothelin receptor antagonist bosentan. Eur. J. Clin. Chem. Clin. Biochem., 33, 463-472.
23. HOCHER, B., RUBENS, C., HENSEN, J. GROSS, P. & BAUER, C. (1992b). Intracellular distribution of endothelin-1 receptors in rat liver cells. Biochem. Biophys. Res. Commun., 184, 498-503.
24. KOHAN, D.E. (1993a). Autocrine role of endothelin in rat inner medullary collecting duct: inhibition of AVP-induced cAMP accumulation. J. Cardiovasc. Pharmacol., 22, Suppl 8: S174-9.
25. KOHAN, D.E (1993b). Endothelins in the kidney: physiology and pathophysiology. Am. J. Kidney Dis., 22, 493-510.
26. KOHAN, D.E., & PADILLA, E. (1994). Endothelin-1 production by rat inner medullary collecting duct: effect of nitric oxide, cGMP, and immune cytokines. Am. J. Physiol., 266, F291-F297.
27. KOUREMBANAS, S., MCQUILLAN, L.P., LEUNG, G.K. & FALLER, D.V. (1993). Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J. Clin. Invest., 93, 99-104.
28. KUEHNLE, H.F., DAHL, D.V. & SCHMIDT, F.H. (1992). Fully enzymatic determination in small volume samples without deproteinization. Nephron., 62, 104-107.
29. KUMAR, C., MWANGI, V., NUTHULAGANTI, P., WU, H.L., PULLEN, M., BRUN, K., AIYAR, H., MORRIS, R.A., NAUGHTON, R. & NAMBI, P. (1994). Cloning and characterization of a novel endothelin receptor from Xenopus heart. J. Biol. Chem., 269, 13414-13420.
30. LAFFI, G., PINZANI, M., MEACCI, E., LA VILLA, G., RENZI, D., BALDI, E., COMINELLI, F., MARRA, F. & GENTILINI, P.I. (1989). Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. Gastroenterology, 96, 167-177.
31. LEPPALUOTO, J. & RUSKOAHO, H. (1992). Endothelin peptides: biological activities, cellular signalling and clinical significance. Ann. Med., 24, 153-161.
32. LÖFFLER, B.M., BREU, V. & CLOZEL, M (1993). Effect of different endothelin receptor antagonists and of the novel non-peptide antagonist Ro 46-2005 on endothelin levels in rat plasma. FEBS Lett., 333, 108-110.
33. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the Folin reagent. J. Biol. Chem., 193, 265-275.
34. LUSCHER, T.F., OEMAR, B.S., BOULANGER, C.M. & HAHN, A.W.A. (1993). Molecular and cellular biology of endothelin and its receptor-Part I (Part II). J. Hypertens., 11, 7-11, 11, 121-126.
35. MCLEAN, E.K., MCLEAN, A.E.M. & SUTTON, P.M. (1969). An improved method for producing cirrhosis of the liver in rats by simultaneous administration of carbon tetrachloride and phenobarbitone. Br. J. Exp. Pathol., 50, 502-506.
36. MOLLER, S., EMMELUTH, C. & HENRIKSEN, J.H. (1993). Elevated circulating plasma endothelin-1 concentrations in cirrhosis. J. Hepatol., 19, 285-90.
37. NAMBI, P., PULLEN, M. & CONTINO, L.C. (1990). Upregulation of renal endothelin receptors in rats with cyclosporine A-induced nephrotoxicity. Eur. J. Pharmacol., 187, 113-116.
38. NAMBI, P., PULLEN, M., WU, H.L., AIYAR, N., OHLSTEIN, E.H. & EDWARDS, R.M. (1992). Identification of endothelin receptor subtypes in human renal cortex and medulla using subtype-selective ligands. Endocrinology, 131, 1081-1086.
39. NANJI, A.A., KHWAJA, S., KHETTRY, U. & SADRZADEH, S.M. (1994). Plasma endothelin levels in chronic ethanol fed rats: relationship to pathologic liver injury. Life Sci., 54, 423-8.
40. NOLAN, J.P. (1975). The role of endotoxin in liver injury. Gastroenterology, 69, 1346-1356.
41. ROUBERT, P., CORNET, S., PLAS, P., GUILMARD, C., PIROTZKY, E., CHABRIER, P.E. & BRAQUET, P. (1993a). Upregulation of renal endothelin receptors in glycerol-induced acute renal failure in the rat. J. Cardiovasc. Pharmacol., 22, Suppl 8: S303-5.
42. ROUBERT, P., VIOSSAT, I., LONCHAMPT, M.O., CHAPELAT, M., SCHULZ, J., PLAS, P., GILLARD-ROUBERT, V., CHABRIER, P.E. & BRAQUET, P. (1993b). Endothelin receptor regulation by endothelin synthesis in vascular smooth muscle cells; effects of dexamethasone and phosphoramidone. J. Vasc. Res., 30, 139-144.
43. SOKOLOVSKY, M. (1992). Endothelins and sarafotoxins: physiological regulation receptor subtypes and transmembrane signaling. Pharmacol. Ther., 54, 129-149.
44. TEERLINK, J.R., CARTEAU, J.P., SPRECHER, U., LÖFFLER, B.M., CLOZEL, M. & CLOZEL, J.P. (1995). Role of endogenous endothelin in normal hemodynamic status of anesthetized dogs. Am. J. Physiol., 268, H432-H440.
45. TRIGER, D.R. (1991). Endotoxamia in liver disease-time for reappraisal? J. Hepatol., 12, 136-138.
46. UCHIHARA, M., IZUMI, N., SATO, C. & MARUMO, F. (1992). Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis. Hepatology, 16, 95-9.
47. VALLANCE, P. & MONCADA, S. (1991). Hyperdynamic circulation in cirrhosis: a role for nitric oxide. Lancet, 337, 776-778.
48. VEMULAPALLI, S., CHIU, P.J., RIVELLI, M., FOSTER, C.J. & SYBERTZ, E.J. (1991). Modulation of circulating endothelin levels in hypertension and endotoxaemia in rats. J. Cardiovasc. Pharmacol., 18, 895-903.
49. WARNER, T.D., BATTISTINI, B., ALLCOCK, G.H & VANE, J.R. (1993). Endothelin ETA and ETB receptors mediate vasoconstriction and prostanoid release in the isolated kidney of the rat. Eur. J. Pharmacol., 250, 447-453.
50. YANAGISAWA, M., KURIHARA, H., KIMURA, S., TOMOBE, Y., KOBAYASHI, M., MITSUI, Y., YAZAKI, T. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332, 411-415.
51. YOSHIMURA, A., IDEURA, T., SHIRAI, T., TAIRA, T., IWASAKI, S., KITAOKA, T. & KOSHIKAWA, S. (1993). The distribution of 3H-labeled endothelin in the kidney of liver cirrhosis. Scand. J. Urol. Nephrol., 27, 295-299.